• About us
• Contact

Advertisement

Organisation › Details

Biogen (Group)

Through cutting-edge science and medicine, Biogen discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hematologic conditions and autoimmune disorders. Founded in 1978, Biogen is one of the world’s oldest independent biotechnology companies and patients worldwide benefit from its leading multiple sclerosis and innovative hemophilia therapies. *

 

	Start	2015-03-23 renamed
	Predecessor	Biogen Idec (Group)
	Industry	pharmaceutical
	Industry 2	biopharmaceutical
	Region	Cambridge, MA
	Country	United States (USA)
	Street	225 Binney Street
	City	02142 Cambridge, MA
	Tel	+1-781-464-2000
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for »About Section«:
		Record changed: 2023-07-10

Advertisement

More documents for Biogen (Group)

• [1] European Pharma Oligonucleotide Consortium (EPOC). (1/25/19). Web Site: European Pharma Oligonucleotide Consortium [incl. EPOC Presenation by Roche Orr, 8 November 2018, at EuroTides]. [www.epoconsortium.com, 01/25/19]...

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.